CSPC Innovation Pharmaceutical Co., Ltd.
SZSE:300765.SZ
23.56 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 3,422.173 | 2,195.684 | 1,231.863 | 1,138.745 | 475.142 | 156.393 | 68.225 | 150.589 | 181.269 | 133.794 |
| Short Term Investments
| 0 | 0 | 413.594 | 321.943 | 960.086 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 3,422.173 | 2,195.684 | 1,645.457 | 1,460.688 | 1,435.228 | 156.393 | 68.225 | 150.589 | 181.269 | 133.794 |
| Net Receivables
| 553.014 | 737.89 | 428.664 | 315.329 | 362.678 | 360.315 | 257.416 | 153.744 | 311.764 | 286.78 |
| Inventory
| 223.685 | 238.126 | 216.857 | 110.999 | 124.231 | 129.239 | 113.667 | 66.87 | 68.53 | 76.33 |
| Other Current Assets
| 21.011 | 18.893 | 26.986 | 26.032 | 14.881 | 14.973 | 27.016 | 21.597 | 0.227 | 1.914 |
| Total Current Assets
| 4,219.882 | 3,190.593 | 2,317.964 | 1,913.048 | 1,937.017 | 660.92 | 466.324 | 392.8 | 561.791 | 498.818 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 1,079.782 | 1,054.753 | 595.648 | 727.486 | 678.17 | 645.385 | 579.872 | 500.857 | 327.428 | 270.23 |
| Goodwill
| 0 | 0 | 0 | 3.468 | 3.468 | 3.468 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 48.031 | 50.419 | 42.417 | 55.207 | 57.567 | 59.926 | 62.286 | 64.646 | 54.333 | 56.176 |
| Goodwill and Intangible Assets
| 48.031 | 50.419 | 42.417 | 58.675 | 61.034 | 63.394 | 62.286 | 64.646 | 54.333 | 56.176 |
| Long Term Investments
| 267.069 | 253.489 | -170.408 | -86.069 | -803.801 | -0 | 0 | 0 | 8.348 | 1.113 |
| Tax Assets
| 17.36 | 18.878 | 11.835 | 10.389 | 12.88 | 11.55 | 6.711 | 1.891 | 0.956 | 0.69 |
| Other Non-Current Assets
| 0 | 15.903 | 428.321 | 331.374 | 967.073 | 9.551 | 13.895 | 8.484 | 4.168 | 4.793 |
| Total Non-Current Assets
| 1,412.242 | 1,393.443 | 907.812 | 1,041.855 | 915.356 | 729.879 | 662.764 | 575.878 | 395.234 | 333.003 |
| Total Assets
| 5,632.124 | 4,584.036 | 3,225.776 | 2,954.903 | 2,852.373 | 1,390.799 | 1,129.088 | 968.678 | 957.025 | 831.821 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 173.684 | 178.75 | 68.852 | 64.158 | 92.703 | 75.937 | 58.203 | 71.488 | 28.341 | 37.253 |
| Short Term Debt
| 0.806 | 0.223 | 0.841 | 5.805 | 12.488 | 70.59 | 45.739 | 120 | 0 | 0 |
| Tax Payables
| 28.357 | 39.449 | 17.87 | 11.218 | 17.536 | 24.989 | 12.071 | 18.644 | 5.537 | 4.05 |
| Deferred Revenue
| 19.803 | 396.924 | 159.924 | 25.27 | 22.21 | 186.903 | 160.128 | 149.872 | 0 | 0 |
| Other Current Liabilities
| 316.545 | 6.872 | 1.424 | 139.008 | 273.357 | 15.916 | 10.524 | 18.44 | 144.395 | 221.714 |
| Total Current Liabilities
| 510.838 | 582.768 | 231.04 | 234.242 | 400.759 | 349.346 | 274.595 | 359.8 | 172.736 | 258.968 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 0.841 | 19.8 | 0 | 0.841 | 0 | 0 | 50 | 0 | 120 | 0 |
| Deferred Revenue Non-Current
| 33.258 | 37.208 | 33.727 | 33.313 | 35.657 | 42.106 | 37.566 | 36.861 | 37.461 | 35.691 |
| Deferred Tax Liabilities Non-Current
| 0.024 | 0.065 | 0.671 | 0.449 | 0.646 | 0 | -50 | 0 | -120 | 0 |
| Other Non-Current Liabilities
| -33.258 | 0 | 0 | -0.841 | 0 | 0 | 50 | 0 | 120 | 0 |
| Total Non-Current Liabilities
| 0.866 | 57.073 | 34.398 | 33.761 | 36.304 | 42.106 | 87.566 | 36.861 | 157.461 | 35.691 |
| Total Liabilities
| 511.704 | 639.841 | 265.438 | 268.003 | 437.062 | 391.451 | 362.161 | 396.662 | 330.197 | 294.658 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,170.742 | 618.926 | 546 | 420 | 200 | 150 | 150 | 150 | 150 | 150 |
| Retained Earnings
| 2,552.591 | 1,955.553 | 1,493.655 | 1,245.206 | 995.316 | 742.251 | 532.191 | 350.135 | 262.358 | 186.151 |
| Accumulated Other Comprehensive Income/Loss
| 285.773 | 223.551 | 157.048 | 131.529 | 109.708 | 98.517 | 84.736 | 71.881 | 0 | 0 |
| Other Total Stockholders Equity
| 1,069.703 | 1,137.571 | 755.376 | 881.376 | 1,101.376 | 0 | 0 | 0 | 212.575 | 201.012 |
| Total Shareholders Equity
| 5,078.809 | 3,935.601 | 2,952.079 | 2,678.112 | 2,406.4 | 990.767 | 766.927 | 572.016 | 624.933 | 537.163 |
| Total Equity
| 5,087.162 | 3,944.194 | 2,960.339 | 2,686.9 | 2,415.311 | 999.348 | 766.927 | 572.016 | 626.828 | 537.163 |
| Total Liabilities & Shareholders Equity
| 5,632.124 | 4,584.036 | 3,225.776 | 2,954.903 | 2,852.373 | 1,390.799 | 1,129.088 | 968.678 | 957.025 | 831.821 |